Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
24,399,262
-
Share change
-
-3,796,598
-
Total reported value
-
$52,204,793
-
Put/Call ratio
-
185%
-
Price per share
-
$2.14
-
Number of holders
-
80
-
Value change
-
-$10,629,147
-
Number of buys
-
39
-
Number of sells
-
29
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q3 2019
As of 30 Sep 2019,
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,399,262 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Nuveen Asset Management, LLC, Bank of New York Mellon Corp, CITADEL ADVISORS LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and BANK OF AMERICA CORP /DE/.
This page lists
80
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.